Israel has not only emerged as a pioneering force in developing innovative medtech use cases, but the Startup Nation is also showing strength in scaling its products for the world stage. As more opportunities in the West and East emerge, it’s clear that Israeli medical technology has a bright future. 

Boosted by robust government infrastructure, Israel’s medtech sector is a key market player in digital health, medical devices, biotechnology, and pharmaceutical therapeutics. The nation’s commitment to delivering leading healthcare has attracted plenty of interest from the Americas, Europe, and East Asia. 

The resilience of the sector has been tested repeatedly in recent years, and a strong flurry of landmark M&A activity shows that Israel’s medtech sector remains as strong as ever. 

One of the most notable signs of Israel’s robust market stemmed from Johnson & Johnson’s $1.7 billion acquisition of Caesarea-headquartered heart failure technology company V-Wave in 2024. 

However, other major instances of M&A activity, such as Boston Scientific’s acquisition of SoniVie last year and the 2024 purchase of transcatheter mitral valve replacement company Innovalve Bio Medical by Edwards Lifesciences, demonstrate Israel’s strength on the world stage when it comes to advanced healthcare. 

Such is the power of Israel’s medtech innovation pipelines that Joe Mullings, CEO of the Mullings Group........

© The Times of Israel (Blogs)